A Placebo-controlled, Double-blind, Randomized Trial to Compare the Effect of Treatment on Plaque Burden as Determined by Intravascular Ultrasound and to Evaluate the Efficacy, Pharmacokinetics, Safety, and Tolerability of MDCO-216 Given as Multiple Weekly Infusions in Subjects With a Recent Acute Coronary Syndrome
Latest Information Update: 06 Nov 2021
Price :
$35 *
At a glance
- Drugs MDCO 216 (Primary)
- Indications Acute coronary syndromes
- Focus Proof of concept; Therapeutic Use
- Acronyms MILANO PILOT; PILOT
- Sponsors The Medicines Company
- 12 Jan 2017 This trial was completed in Netherlands, according to European Clinical Trials Database.
- 15 Dec 2016 This trial has been completed in Czech Republic (end date: 26 Oct 2016), according to European Clinical Trials Database.
- 10 Dec 2016 This trial has been completed in Poland (end date: 2016-10-26), according to European Clinical Trials Database.